Elevated free thyroxine and free triiodothyronine probably caused by high-dose biotin intake in a patient with Graves’ disease: a case report
Endocrine Journal · 2023
DOI: 10.1507/endocrj.ej23-0062 ↗Kurz gefasst
Fallbericht in der Zeitschrift Endocrine Journal, 2023. Verfasst von Kento Shimmaru und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima 730-8619, Japan. Hauptthemen laut MEDLINE: Triiodothyronine, Graves Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima 730-8619, Japan.
- Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan.
Zitieren
APA
Shimmaru, K., Inami, M., Hamaoka, A., Fujiwara, N., Morioka, T., Emoto, M., & Kamei, N. (2023). Elevated free thyroxine and free triiodothyronine probably caused by high-dose biotin intake in a patient with Graves’ disease: a case report. Endocrine Journal. https://doi.org/10.1507/endocrj.ej23-0062
Vancouver
Shimmaru K, Inami M, Hamaoka A, Fujiwara N, Morioka T, Emoto M, et al. Elevated free thyroxine and free triiodothyronine probably caused by high-dose biotin intake in a patient with Graves’ disease: a case report. Endocrine Journal. 2023. doi:10.1507/endocrj.ej23-0062
BibTeX
@article{Shimmaru2023,
author = {Shimmaru, Kento and Inami, Mitsuhiro and Hamaoka, Aya and Fujiwara, Noriko and Morioka, Tomoaki and Emoto, Masanori and Kamei, Nozomu},
title = {Elevated free thyroxine and free triiodothyronine probably caused by high-dose biotin intake in a patient with Graves’ disease: a case report},
journal = {Endocrine Journal},
year = {2023},
doi = {10.1507/endocrj.ej23-0062}
}
EUVIMED